top of page

Eli Lilly antibody trial paused over safety concern

A government sponsored clinical trial by Eli Lilly was paused. Spokes person Molly McCully informed economictimes that company is more concerned towards safety of the patient and so the trial was paused. Same was also confirmed by the email sent to researchers from government officials.

Eli Lilly is perusing the experimental treatment for COVID-19 that uses monoclonal antibodies.



Obtuvo 0 de 5 estrellas.
Aún no hay calificaciones

Agrega una calificación
bottom of page